Medical and Pharmaceutical

Recent regulatory amendments signal greater acceptance of cannabis as medicine in the country

Industry organizations say they've taken action against the new regulations

As of Jan. 1, up to 6M patients can look forward to significantly reduced costs and a simpler application process

It's unclear what will happen with the proposed regulatory framework

Most licences will be issued without a fixed end date

The Canadian firm has partnered with a subsidiary of US pharmaceutical firm Merger Group

Some study participants stopped using cannabis out of fear of potential harm to the fetus, while others stopped because of social stigma, guilt and health reasons

Initial deliveries have been made to local pharmacies with planned shipments for Germany and the UK

Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS

The firm will celebrate by ringing the opening bell at the stock exchange on Thursday

Compared to non-consumers, people who used cannabis 20 days a month were more likely to experience both extremes of sleep duration

The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services

The company says it expects changes to Canadian law that will allow pharmacies to sell cannabis directly to patients

While THC can cause temporary dose-dependent psychotic symptoms, researchers note that some clinical findings suggest CBD has a different effect

Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics

A developed industry could be worth £1.2 billion and create about 41,000 jobs

The Montreal-based producer will have access to additional cultivation space, more than doubling annual production capacity

The health minister says the country has only a third of the October shipment left and more isn't expected until next month

On top of cannabis research, the centre will act as a knowledge exchange between medical institutions in other countries like Canada

But it's unclear how the bill will do in the upper house, and the Bolsonaro administration opposes cannabis use

The company says a majority of new sales growth is coming from its focus on medical cannabis

While pleased with a growing acceptance of cannabis, Anutin Charnvirakul is promising greater access

While there's only limited data on the effects of cannabis in minors, researchers suggest it as an alternative to surgery in severe cases

The company says it will use data from its clinics in Colombia and Peru to help treat patients in the UK

Data was collected via the Strainprint app, and is some of the first research of its kind to focus on regulated products

The state's cannabis control board announced legislative changes to increase patient access at a meeting Oct. 5

Regulations have been laid out for weed testing at work and home cultivation for certified medical patients

Supporters of the bill hope it isn't vetoed by the president

It’s the first federal grant to be awarded for psychedelic treatment research in 50 years

In a report by several industry groups, its authors continue to argue for less restriction to battle the still-thriving illicit market

After a spike in demand for research, the DEA is proposing increased quotas for controlled substances including MDMA, LSD, psilocybin and cannabis

All the bills seek to regulate a cannabis market, as well as define rules for cannabis social clubs and cultivation

A majority of physicians aren't equipped to talk about medical cannabis, and patients often look for information elsewhere

Taking sublingual oils proved beneficial for chronic pain, nausea, anxiety and a list of other common ailments

A loss of $2.6M this quarter represents a 58% drop

The firm says expenses will increase as research and 'important progress' continues

A number of the medical cannabis maker's products are available to Canadian patients

Pathway Health is helping pharmacies prepare in anticipation of changes to Canada's pot laws

The agencies are trying to crack down on the alternative cannabinoid after a surge in availability and adverse events this year

The Cross-Party Group on Medical Cannabis hopes to shed light on developing treatments